Related references
Note: Only part of the references are listed.被撤回的出版物: HMGA2 functions as a competing endogenous RNA to promote lung cancer progression (Retracted article. See vol. 523, 2015)
Madhu S. Kumar et al.
NATURE (2014)
Development of siRNA Payloads to Target KRAS-Mutant Cancer
Tina L. Yuan et al.
CANCER DISCOVERY (2014)
HMGA2 Is a Driver of Tumor Metastasis
Asahiro Morishita et al.
CANCER RESEARCH (2013)
Let-7b expression determines response to chemotherapy through the regulation of Cyclin D1 in Glioblastoma
Yong Guo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Stem Cell Marker Nestin Is Critical for TGF-β1-Mediated Tumor Progression in Pancreatic Cancer
Huei-Ting Su et al.
MOLECULAR CANCER RESEARCH (2013)
Let-7c Governs the Acquisition of Chemo- or Radioresistance and Epithelial-to-Mesenchymal Transition Phenotypes in Docetaxel-Resistant Lung Adenocarcinoma
Shi-Yun Cui et al.
MOLECULAR CANCER RESEARCH (2013)
The hunting of targets: challenge in miRNA research
F. Akbari Moqadam et al.
LEUKEMIA (2013)
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Jonathan M. Ostrem et al.
NATURE (2013)
Purvalanol A, Olomoucine II and Roscovitine Inhibit ABCB1 Transporter and Synergistically Potentiate Cytotoxic Effects of Daunorubicin In Vitro
Daniela Cihalova et al.
PLOS ONE (2013)
Mutant KRAS is a druggable target for pancreatic cancer
Elina Zorde Khvalevsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction
Fumi Shima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer
S. Ali et al.
BRITISH JOURNAL OF CANCER (2012)
Let-7 Expression Is a Significant Determinant of Response to Chemotherapy through the Regulation of IL-6/STAT3 Pathway in Esophageal Squamous Cell Carcinoma
Keijiro Sugimura et al.
CLINICAL CANCER RESEARCH (2012)
Oncogenic Pathways, Molecularly Targeted Therapies, and Highlighted Clinical Trials in Non-Small-Cell Lung Cancer (NSCLC)
Thanyanan Reungwetwattana et al.
CLINICAL LUNG CANCER (2012)
Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1
Benjamin Boyerinas et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non-Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
Guenaelle Levallet et al.
MOLECULAR CANCER THERAPEUTICS (2012)
HMGA2 Overexpression-Induced Ovarian Surface Epithelial Transformation Is Mediated Through Regulation of EMT Genes
Jingjing Wu et al.
CANCER RESEARCH (2011)
Paclitaxel as second-line chemotherapy in patients with gemcitabine-refractory pancreatic cancer: a retrospective study
Shimpei Maeda et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2011)
Knockdown of Oncogenic KRAS in Non-Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
Noriaki Sunaga et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice
Phong Trang et al.
MOLECULAR THERAPY (2011)
4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors
Qing-Bai She et al.
CANCER CELL (2010)
The role of let-7 in cell differentiation and cancer
Benjamin Boyerinas et al.
ENDOCRINE-RELATED CANCER (2010)
Regression of murine lung tumors by the let-7 microRNA
P. Trang et al.
ONCOGENE (2010)
Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
Yiwei Li et al.
CANCER RESEARCH (2009)
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Thiruvengadam Arumugam et al.
CANCER RESEARCH (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Let-7 and miR-200 microRNAs Guardians against pluripotency and cancer progression
Marcus E. Peter
CELL CYCLE (2009)
MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
Dawn R. Cochrane et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Jeffrey A. Engelman
NATURE REVIEWS CANCER (2009)
Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine
J. Souglakos et al.
BRITISH JOURNAL OF CANCER (2008)
The let-7 microRNA reduces tumor growth in mouse models of lung cancer
Aurora Esquela-Kerscher et al.
CELL CYCLE (2008)
HMGA2 and Smads Co-regulate SNAIL1 Expression during Induction of Epithelial-to-Mesenchymal Transition
Sylvie Thuault et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
Jeffrey A. Engelman et al.
NATURE MEDICINE (2008)
Suppression of non-small cell lung tumor development by the let-7 microRNA family
Madhu S. Kumar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Iet-7 regulates self renewal and tumorigenicity of breast cancer cells
Fengyan Yu et al.
CELL (2007)
Class III β-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia
K. M. Lee et al.
HISTOPATHOLOGY (2007)
Class III β-tubulin mediates sensitivity to chemotherapeutic drugs in non-small cell lung cancer
Pei Pei Gan et al.
CANCER RESEARCH (2007)
The let-7 MicroRNA represses cell proliferation pathways in human cells
Charles D. Johnson et al.
CANCER RESEARCH (2007)
Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma
Barbara A. Frederick et al.
MOLECULAR CANCER THERAPEUTICS (2007)
The tumor suppressor microRNA let-7 represses the HMGA2 oncogene
Yong Sun Lee et al.
GENES & DEVELOPMENT (2007)
Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells
Y. Nakano et al.
BRITISH JOURNAL OF CANCER (2007)
Increased expression of high mobility group A proteins in lung cancer
V. K. Sarhadi et al.
JOURNAL OF PATHOLOGY (2006)
被撤回的出版物: RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine (Retracted article. See FEB, 2023)
MS Duxbury et al.
ONCOGENE (2004)
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival
J Takamizawa et al.
CANCER RESEARCH (2004)
An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue
N Abe et al.
BRITISH JOURNAL OF CANCER (2003)
The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells
E Batlle et al.
NATURE CELL BIOLOGY (2000)
Share Paper
